190 related articles for article (PubMed ID: 27174719)
1. Preclinical breast effects of a tissue selective estrogen complex (TSEC) including conjugated estrogen with bazedoxifene.
Santen RJ; Song Y; Wang JP; Yue W
J Steroid Biochem Mol Biol; 2017 Jun; 170():61-64. PubMed ID: 27174719
[TBL] [Abstract][Full Text] [Related]
2. Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice.
Song Y; Santen RJ; Wang JP; Yue W
Endocrinology; 2012 Dec; 153(12):5706-15. PubMed ID: 23070546
[TBL] [Abstract][Full Text] [Related]
3. Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen.
Yue W; Wang J; Atkins KA; Bottalico L; Mesaros C; Blair IA; Santen RJ
Int J Cancer; 2018 Sep; 143(5):1259-1268. PubMed ID: 29577272
[TBL] [Abstract][Full Text] [Related]
4. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of a bazedoxifene/conjugated equine estrogen combination on human breast cancer cells in vitro.
Song Y; Santen RJ; Wang JP; Yue W
Endocrinology; 2013 Feb; 154(2):656-65. PubMed ID: 23254198
[TBL] [Abstract][Full Text] [Related]
6. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
7. Differential utilization of nuclear and extranuclear receptor signaling pathways in the actions of estrogens, SERMs, and a tissue-selective estrogen complex (TSEC).
Madak-Erdogan Z; Gong P; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 2016 Apr; 158():198-206. PubMed ID: 26689478
[TBL] [Abstract][Full Text] [Related]
8. Effects of bazedoxifene acetate with and without conjugated equine estrogens on the breast of postmenopausal monkeys.
Ethun KF; Wood CE; Register TC; Cline JM; Appt SE; Clarkson TB
Menopause; 2012 Nov; 19(11):1242-52. PubMed ID: 23103754
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens.
Chang KC; Wang Y; Bodine PV; Nagpal S; Komm BS
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):117-24. PubMed ID: 19914376
[TBL] [Abstract][Full Text] [Related]
10. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.
Naqvi H; Sakr S; Presti T; Krikun G; Komm B; Taylor HS
Biol Reprod; 2014 Jun; 90(6):121. PubMed ID: 24740602
[TBL] [Abstract][Full Text] [Related]
11. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
Komm BS; Mirkin S; Jenkins SN
Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
[TBL] [Abstract][Full Text] [Related]
12. Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.
Pinkerton JV; Komm BS; Mirkin S
Climacteric; 2013 Dec; 16(6):618-28. PubMed ID: 23805785
[TBL] [Abstract][Full Text] [Related]
13. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
Tella SH; Gallagher JC
Expert Opin Pharmacother; 2013 Dec; 14(17):2407-20. PubMed ID: 24093499
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Experimental Arthritis and Associated Bone Loss by a Tissue-Selective Estrogen Complex.
Andersson A; Bernardi AI; Nurkkala-Karlsson M; Stubelius A; Grahnemo L; Ohlsson C; Carlsten H; Islander U
Endocrinology; 2016 Mar; 157(3):1013-20. PubMed ID: 26745543
[TBL] [Abstract][Full Text] [Related]
15. [Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
Calaf Alsina J; Coronado Martín PJ
Med Clin (Barc); 2013 Mar; 140(6):266-71. PubMed ID: 23276611
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.
Pinkerton JV; Abraham L; Bushmakin AG; Cappelleri JC; Racketa J; Shi H; Chines AA; Mirkin S
J Womens Health (Larchmt); 2014 Jan; 23(1):18-28. PubMed ID: 24206058
[TBL] [Abstract][Full Text] [Related]
17. Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model.
Ethun KF; Wood CE; Cline JM; Register TC; Appt SE; Clarkson TB
Menopause; 2013 Jul; 20(7):777-84. PubMed ID: 23793168
[TBL] [Abstract][Full Text] [Related]
18. Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators.
Pinkerton JV; Conner EA
Climacteric; 2019 Apr; 22(2):140-147. PubMed ID: 30895900
[TBL] [Abstract][Full Text] [Related]
19. Effects of menopausal hormonal therapy on occult breast tumors.
Santen RJ; Song Y; Yue W; Wang JP; Heitjan DF
J Steroid Biochem Mol Biol; 2013 Sep; 137():150-6. PubMed ID: 23748149
[TBL] [Abstract][Full Text] [Related]
20. Bazedoxifene/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women.
Palacios S; Mejía Ríos A
Drugs Today (Barc); 2015 Feb; 51(2):107-16. PubMed ID: 25756066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
